Events & presentations

Internal link Conference call top-line results Phase 2/3 Illuminate trial

ProQR to host a conference call to discuss the top-line results of the Phase 2/3 Illuminate clinical trial of investigational RNA therapy sepofarsen in CEP20-mediated LCA10.

• Add Conference call top-line results Phase 2/3 Illuminate trial to calender

Internal link ProQR Analyst Event

During this webcast ProQR leadership will highlight key advancements from its clinical-stage pipeline and Axiomer® RNA editing platform.

• Add ProQR Analyst Event to calender

Internal link American Academy of Ophthalmology (AAO) Annual Meeting 2021

ProQR to participate in the American Academy of Ophthalmology (AAO) Annual Meeting 2021

• Add American Academy of Ophthalmology (AAO) Annual Meeting 2021 to calender

Internal link EFF Fall Virtual Summit 2021 - The Science of RNA Therapies

The Eye on the Future Forum (EFF) is a platform hosted by ProQR on innovative clinical development approaches for genetic eye diseases. This Fall Summit will explore the Science of RNA Therapies.

• Add EFF Fall Virtual Summit 2021 - The Science of RNA Therapies to calender

• Healthcare professionals
• Patient

Internal link Axiomer Investor Call

ProQR management will host an investor conference call and webcast to discuss the Company’s Axiomer RNA editing technology platform following the recently announced partnership with Lilly. 

• Add Axiomer Investor Call to calender